These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 7969910

  • 1. Sparing of the dopaminergic neurons containing calbindin-D28k and of the dopaminergic mesocortical projections in weaver mutant mice.
    Gaspar P, Ben Jelloun N, Febvret A.
    Neuroscience; 1994 Jul; 61(2):293-305. PubMed ID: 7969910
    [Abstract] [Full Text] [Related]

  • 2. Vulnerability of midbrain dopaminergic neurons in calbindin-D28k-deficient mice: lack of evidence for a neuroprotective role of endogenous calbindin in MPTP-treated and weaver mice.
    Airaksinen MS, Thoenen H, Meyer M.
    Eur J Neurosci; 1997 Jan; 9(1):120-7. PubMed ID: 9042576
    [Abstract] [Full Text] [Related]

  • 3. Midbrain dopaminergic neurons in the mouse: co-localization with Calbindin-D28K and calretinin.
    Liang CL, Sinton CM, German DC.
    Neuroscience; 1996 Nov; 75(2):523-33. PubMed ID: 8931015
    [Abstract] [Full Text] [Related]

  • 4. Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells.
    German DC, Manaye KF, Sonsalla PK, Brooks BA.
    Ann N Y Acad Sci; 1992 May 11; 648():42-62. PubMed ID: 1353337
    [Abstract] [Full Text] [Related]

  • 5. Decreased susceptibility to oxidative stress underlies the resistance of specific dopaminergic cell populations to paraquat-induced degeneration.
    McCormack AL, Atienza JG, Langston JW, Di Monte DA.
    Neuroscience; 2006 Aug 25; 141(2):929-937. PubMed ID: 16677770
    [Abstract] [Full Text] [Related]

  • 6. Calbindin D-28K in the dopaminergic mesocortical projection of a monkey (Aotus trivirgatus).
    Gaspar P, Heizmann CW, Kaas JH.
    Brain Res; 1993 Feb 12; 603(1):166-72. PubMed ID: 8095839
    [Abstract] [Full Text] [Related]

  • 7. Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K.
    Yamada T, McGeer PL, Baimbridge KG, McGeer EG.
    Brain Res; 1990 Sep 03; 526(2):303-7. PubMed ID: 2257487
    [Abstract] [Full Text] [Related]

  • 8. Calbindin-D28k-containing neurons in the human hypothalamus: relationship to dopaminergic neurons.
    Sanghera MK, Zamora JL, German DC.
    Neurodegeneration; 1995 Dec 03; 4(4):375-81. PubMed ID: 8846230
    [Abstract] [Full Text] [Related]

  • 9. Melanin, tyrosine hydroxylase, calbindin and substance P in the human midbrain and substantia nigra in relation to nigrostriatal projections and differential neuronal susceptibility in Parkinson's disease.
    Gibb WR.
    Brain Res; 1992 May 29; 581(2):283-91. PubMed ID: 1382801
    [Abstract] [Full Text] [Related]

  • 10. Midbrain dopaminergic neurons in the mouse that contain calbindin-D28k exhibit reduced vulnerability to MPTP-induced neurodegeneration.
    Liang CL, Sinton CM, Sonsalla PK, German DC.
    Neurodegeneration; 1996 Dec 29; 5(4):313-8. PubMed ID: 9117542
    [Abstract] [Full Text] [Related]

  • 11. Expression of calbindin D28K in the dopaminergic mesotelencephalic system in embryonic and fetal human brain.
    Verney C, Zecevic N, Ezan P.
    J Comp Neurol; 2001 Jan 01; 429(1):45-58. PubMed ID: 11086288
    [Abstract] [Full Text] [Related]

  • 12. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry.
    Damier P, Hirsch EC, Agid Y, Graybiel AM.
    Brain; 1999 Aug 01; 122 ( Pt 8)():1421-36. PubMed ID: 10430829
    [Abstract] [Full Text] [Related]

  • 13. Calbindin-D28k in nerve cell nuclei.
    German DC, Ng MC, Liang CL, McMahon A, Iacopino AM.
    Neuroscience; 1997 Dec 01; 81(3):735-43. PubMed ID: 9316025
    [Abstract] [Full Text] [Related]

  • 14. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.
    Damier P, Hirsch EC, Agid Y, Graybiel AM.
    Brain; 1999 Aug 01; 122 ( Pt 8)():1437-48. PubMed ID: 10430830
    [Abstract] [Full Text] [Related]

  • 15. Neuroactive peptides exist in the midbrain dopaminergic neurons that contain calbindin-D28k.
    German DC, Liang CL.
    Neuroreport; 1993 May 01; 4(5):491-4. PubMed ID: 8513124
    [Abstract] [Full Text] [Related]

  • 16. On the altered expression of tyrosine hydroxylase and calbindin-D 28kD immunoreactivities and viability of neurons in the ventral tegmental area of Tsai following injections of 6-hydroxydopamine in the medial forebrain bundle in the rat.
    Tan Y, Williams EA, Lancia AJ, Zahm DS.
    Brain Res; 2000 Jun 30; 869(1-2):56-68. PubMed ID: 10865059
    [Abstract] [Full Text] [Related]

  • 17. Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease?
    Mouatt-Prigent A, Agid Y, Hirsch EC.
    Brain Res; 1994 Dec 30; 668(1-2):62-70. PubMed ID: 7704619
    [Abstract] [Full Text] [Related]

  • 18. Dopaminergic neurons expressing calbindin in normal and parkinsonian monkeys.
    Lavoie B, Parent A.
    Neuroreport; 1991 Oct 30; 2(10):601-4. PubMed ID: 1684519
    [Abstract] [Full Text] [Related]

  • 19. The neuroprotective effect of overexpression of calbindin-D(28k) in an animal model of Parkinson's disease.
    Yuan HH, Chen RJ, Zhu YH, Peng CL, Zhu XR.
    Mol Neurobiol; 2013 Feb 30; 47(1):117-22. PubMed ID: 22923348
    [Abstract] [Full Text] [Related]

  • 20. Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death?
    Mouatt-Prigent A, Karlsson JO, Agid Y, Hirsch EC.
    Neuroscience; 1996 Aug 30; 73(4):979-87. PubMed ID: 8809817
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.